Samsung Biologics 2020 net profit up 18.8 pct. to 241 bln won
SEOUL, Samsung Biologics Co. on Tuesday reported its 2020 net income of 241 billion won (US$217.8 million), up 18.8 percent from a year earlier.
The company said in a regulatory filing that it posted 292.8 billion won in operating profit for the year, compared with 91.7 billion on-year. Annual sales rose 66 percent to 1.16 trillion won.
Source: Yonhap News Agency